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Parasites and competitors are important for regulating pathogen densities and subsequent disease dynamics. It is, however,
unclear to what extent this is driven by ecological and evolutionary processes. Here, we used experimental evolution to study
the eco-evolutionary feedbacks among Ralstonia solanacearum bacterial pathogen, Ralstonia-specific phage parasite, and Bacillus
amyloliquefaciens competitor bacterium in the laboratory and plant rhizosphere. We found that while the phage had a small
effect on pathogen densities on its own, it considerably increased the R. solanacearum sensitivity to antibiotics produced by
B. amyloliquefaciens. Instead of density effects, this synergy was due to phage-driven increase in phage resistance that led to
trade-off with the resistance to B. amyloliquefaciens antibiotics. While no evidence was found for pathogen resistance evolution
to B. amyloliquefaciens antibiotics, the fitness cost of adaptation (reduced growth) was highest when the pathogen had evolved
in the presence of both parasite and competitor. Qualitatively similar patterns were found between laboratory and greenhouse
experiments even though the evolution of phage resistance was considerably attenuated in the tomato rhizosphere. These results
suggest that evolutionary trade-offs can impose strong constraints on disease dynamics and that combining phages and antibiotic-
producing bacteria could be an efficient way to control agricultural pathogens.
KEY WORDS: Experimental evolution, fitness cost, interference competition, phage therapy, Ralstonia solanacearum, trade-off.
Microbial species interactions can affect disease dynamics by
changing the relative and absolute pathogen densities in the host-
associated microbiomes (Mendes et al. 2011; Mueller and Sachs
2015; Wei et al. 2015b; Donaldson et al. 2016). These effects can
be driven by ecological dynamics where antagonistic microbes
directly reduce pathogen densities via parasitism or competition
(Wei et al. 2015a,b), or alternatively, by evolutionary dynamics
∗These authors contributed equally to this work.
This article corresponds to Sonia S. (2017), Digest: Beating pathogens at their
own game. Evolution. DOI:10.1111/evo.13184.
if pathogen adaptation to phages results in trade-offs with life-
history traits such as virulence (Friman et al. 2009; Addy et al.
2012a; Bull and Lauring 2014; Friman and Buckling 2014). De-
spite the recent advances in microbiome research, the relative im-
portance of ecological versus evolutionary dynamics for pathogen
density dynamics and disease development are still unclear. Here,
we use a direct experimental approach to study the growth dynam-
ics of the plant pathogen Ralstonia solanacearum. In presence of
a parasitic phage and a bacterial competitor.
Bacteriophages are bacteria-specific viruses that are bacte-
riophages are important for regulating bacterial densities across
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different environments. For example, the densities of the human
pathogenic bacterium Vibrio cholerae and its parasitic phages
show seasonal dynamics where cholera incidences inversely cor-
relate with the phage prevalence in the environment (Faruque et al.
2005). Similarly, phage and bacteria density dynamics have been
shown to correlate positively in time on a long-lived chestnut tree
host (Koskella 2013). Phages can regulate bacterial densities and
have also been used in applied context of phage therapy to kill the
pathogenic bacteria in the site of infection (Levin and Bull 2004).
One significant limitation of phage-mediated control of bacte-
ria is rapid resistance evolution, which can occur in a matter of
days in laboratory conditions (Lenski and Levin 1985; Hall et al.
2012; Friman and Buckling 2014; Scanlan et al. 2015). While
the evolution of resistance is considerably slower in the natural
environments (Gomez and Buckling 2011; Gomez et al. 2015),
observations suggest that temporal and spatial patterns can con-
strain phage-mediated control of bacterial pathogens in natural
communities (Vos et al. 2009; Koskella 2013, 2014). However,
evolving resistance does not come for free and often leads to
fitness costs in terms of poorer functioning of some other bac-
terial life-history trait. Such evolutionary trade-offs include, for
example, reduced bacterial growth (Hall et al. 2012; Scanlan et al.
2015) via loss of phage receptors that are not only used by the
phage but also by the bacteria to uptake nutrients (Lenski and
Levin 1985), reduced bacterial ability to adapt to abiotic condi-
tions (Scanlan et al. 2015), impairment of mismatch-repair genes
(Pal et al. 2007), and reduced expression of bacterial virulence
genes (Addy et al. 2012a). These kind of trade-offs could expose
a chink in the bacterial armor and potentially reduce the survival
of phage-resistant bacteria in complex microbial communities.
Besides parasites, pathogenic bacteria are constantly faced by
competition with other bacteria: resource competition can signif-
icantly limit the establishment and survival of invading bacterial
pathogens in the rhizosphere due to competitive exclusion (Wei
et al. 2015b). Bacteria can directly inhibit each other by produc-
ing bacteriocins (Ghoul et al. 2015) and antibiotics (Wei et al.
2011; Yuan et al. 2012). While the competitive interactions can
have important roles for pathogen densities and disease dynam-
ics (Wei et al. 2011, 2015a), it is possible that pathogens can
overcome these constraints via adaptation. For example, bacterial
resource consumption patterns can evolve rapidly (Riley et al.
2001; Craig et al. 2005; Gomez et al. 2015) and it is well known
that bacteria can evolve resistance to antibiotics (MacLean et al.
2010). Evolving in response to one selection pressure is, however,
context dependent and could be altered in the presence of other
selective agents (Friman and Buckling 2014; Gomez et al. 2015).
Phage-antibiotic synergy (PAS), where phage selection increases
bacterial susceptibility to antibiotics (Chan et al. 2016; Torres-
Barcelo et al. 2016; Torres-Barcelo and Hochberg 2016), could
be an important constraint on pathogen evolution in the presence
of both parasites and antibiotic-producing bacteria. One potential
mechanism for PAS is phage-mediated changes in bacterial cell
morphology (cell enlargement, elongation, and filamentation; Zak
and Kradolfer 1979), which then affect the rate of phage produc-
tion and sensitivity to lysis (Comeau et al. 2007; Kamal and
Dennis 2015). While PAS has been studied in the context of clin-
ical antibiotics, there are no studies linking PAS with naturally
occurring rhizosphere bacteria that produce multiple different an-
tibiotics in agricultural context. Furthermore, it is still somewhat
unclear if antibiotic selection makes pathogens more susceptible
to phages.
Understanding the interplay between ecological and evolu-
tionary processes for host–pathogen interactions is especially im-
portant in the context of plant microbiomes: rhizosphere bacteria
compete fiercely for the space and resources with the invading
pathogens forming the first line of plant defense. Better under-
standing of such tripartite interactions could be important from
the applied perspective. Microbial-based biocontrol—the use of
naturally occurring competitors, predators, and parasites of the
pathogen—has showed promising results for disease control in
the plant rhizosphere (Mendes et al. 2011; Mueller and Sachs
2015; Wei et al. 2015b). Biocontrol outcomes are unpredictable
for a variety of reasons including temporally changing abiotic
conditions (Wei et al. 2011, 2015a) and pathogen resistance evo-
lution to biocontrol agents (Handelsman and Stabb 1996; Duffy
et al. 2003).
Here, we used an experimental evolution approach to study
how Ralstonia-specific phage parasite and competing Bacillus
amyloliquefaciens bacterium control R. solanacearum pathogen
densities alone and in combination in the laboratory in vitro
and tomato plant rhizosphere in vivo. Ralstonia solanacearum
bacterium causes lethal vascular bacterial wilt in many impor-
tant crops and is spread globally (Hayward 1991). This highly
complex pathogen is able to adapt to multiple different envi-
ronmental niches and isolates vary considerably in their host
plant range, geographical distribution, pathogenicity, epidemi-
ological relationships, and physiological properties (Genin and
Denny 2012). It has been previously shown that both phages
and antibiotic-producing bacteria can control R. solanacearum
infection to some extent (Wei et al. 2011, 2015a; Addy et al.
2012a,b; Yamada 2012). However, to our knowledge, there are no
studies looking at the interactive effect of phages and antibiotic-
producing bacteria on bacterial wilt dynamics on ecological and
evolutionary timescales. Bacillus amyloliquefaciens inhibits R.
solanacearum by producing antibacterial secondary metabolites
such as lipopeptides, surfactins, and lantibiotics that target bacte-
rial lipopolysaccharides (Chen et al. 2006, 2007; Yuan et al. 2012),
while Ralstonia-specific phages use bacterium as their hosts to
produce new phage particles before eventually killing them. We
first looked at the effects of the phage and B. amyloliquefaciens on
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pathogen population densities and then quantified the pathogen
resistance evolution to both phage and B. amyloliquefaciens.
These eco-evolutionary dynamics were further correlated with
the host survival in a separate greenhouse experiment. We hy-
pothesized that a phage–B. amyloliquefaciens combination should
be more effective in controlling pathogen densities compared to
phage-only or B. amyloliquefaciens-only treatments. This effect
could be driven by density-dependent ecological dynamics where
higher phage and B. amyloliquefaciens densities lead to more ef-
ficient pathogen suppression, or alternatively, by evolutionary dy-
namics where selection leads to evolutionary trade-offs (Friman
and Buckling 2014) or PAS (Comeau et al. 2007; Kamal and
Dennis 2015; Torres-Barcelo et al. 2016).
Materials and Methods
STRAINS AND CULTURE CONDITIONS
Ralstonia solanacearum strain QL-Rs1115 (Wei et al. 2011;
CGMCC accession No. 9487, China General Microbiology Cul-
ture Collection Center) was labeled with red fluorescent protein
(abbreviated as QL-RFP) and grown at 30°C in a liquid nutrient
medium (10 g glucose, 5 g tryptone, 3 g beef extract, and 0.5 g
yeast extract/l). Bacillus amyloliquefaciens strain T-5 (Tan et al.
2013; CGMCC accession No. 8547, China General Microbiology
Culture Collection Center) was labeled with green fluorescent
protein (abbreviated as T-5-GFP) and grown at 30°C in the liq-
uid nutrient medium (Tan et al. 2015). Fluorescent-labeled strains
were used only in the laboratory experiment, whereas nonlabeled
strains were used in the greenhouse experiment. Phage (isolated
from Qilin town, Jiangsu province, China, 118°57′ E, 32°03′
N) stock solutions were prepared by coculturing with ancestral
QL-RFP strain for 24 h before chloroforming and centrifuging
to purify phages from bacteria. Phage solutions were stored at
4°C (Friman and Buckling 2013). Phage produced clear plaques
on bacterial overlays, short tail, and a diameter around 60 nm
(Fig. S1). This suggests that it was likely a lytic phage and poten-
tially belonged to the family of Podoviridae.
LABORATORY SELECTION EXPERIMENT IN VITRO
AND ISOLATION OF EVOLVED PATHOGEN COLONIES
We first tested the effectiveness of phage and B. amyloliquefa-
ciens in vitro by using factorial experimental design with four
treatments where R. solanacearum bacteria were cultured alone
(control treatment), in the presence of B. amyloliquefaciens T-5-
GFP (competition treatment), phage (phage treatment), or both
phage and B. amyloliquefaciens T-5-GFP (combinatory treat-
ment). We performed the experiment on a 48-well microplate
with 700 µl volumes per population and used only the 24 wells
in the middle of the microplate for our experimental populations
(the edge wells were filled with dH2O to prevent evaporation).
Each microcosm was initially inoculated with approximately 106
R. solanacearum cells. Six of the microcosms were inoculated
with approximately 105 cells of B. amyloliquefaciens T-5-GFP
bacterium, six microcosms with approximately 106 phage par-
ticles, and six microcosms with approximately 105 cells of B.
amyloliquefaciens T-5-GFP and 106 phage particles. The remain-
ing six microcosms contained only the pathogen. The microplate
was incubated at 30°C with shaking (170 rpm), and at every 24 h,
we measured the growth of bacteria with SpectraMax M5 Plate
reader (Molecular Devices, Sunnyvale, CA) by characterizing the
average fluorescence intensity. Ralstonia solanacearum growth
was measured as a red fluorescence signal (excitation: 587 nm,
emission: 610 nm) and B. amyloliquefaciens T-5-GFP growth as a
green fluorescence signal (excitation: 485 nm, emission: 533 nm).
Subsamples of all populations (100 µl) were cryopreserved at –
80°C in 15% glycerol at 48- and 96-h sampling points to further
study the evolutionary dynamics. To this end, we isolated both
bacteria and phages from three randomly selected replicate pop-
ulations from each treatment at both time points (bacteria from
every treatment and phages from phage-containing treatments).
Bacteria were isolated by serial dilution and plating on semise-
lective medium (M-SMSA) (Elphinstone et al. 1996). After 48 h
of growth at 30°C, 24 colonies were picked randomly from
each treatment replicate population, grown individually for
24 h at 30°C in liquid medium in 96-well microplates and cryop-
reserved at –80°C in 15% glycerol. Similarly, phage populations
were isolated from the same corresponding populations where
the bacteria were isolated with chloroform treatment and stored
at 4°C for evolutionary measurements (Friman and Buckling
2014).
MEASURING EVOLUTIONARY CHANGES
IN PATHOGEN RESISTANCE TO PHAGE AND PHAGE
INFECTIVITY
Pathogen resistance and phage infectivity were assayed at the
population level as the proportion of resistant bacteria by using
spotting assays (Scanlan et al. 2015). Briefly, overnight-grown
bacterial colonies were mixed with cooled-down soft agar (with
7% agar concentration) and 2 µl of the associated phage popu-
lation was spotted over the bacterial culture. Bacterial resistance
and phage infectivity were determined after 24-h growth as the
proportion of bacterial lawns that had plaques, which is indica-
tive of bacterial lysis due to phage infection. To study potential
coevolutionary changes, the resistance of bacteria isolated at 48-h
time point was tested against phages isolated from the past (0 h),
contemporary (48 h), and future (96 h) time points. Similarly, the
infectivity of phage isolated at 48-h time point was tested against
bacteria isolated from the past (0 h), contemporary (48 h), and
future (96 h) time points.
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MEASURING EVOLUTIONARY CHANGES
IN PATHOGEN DEFENSE AGAINST ANTIBIOTICS
PRODUCED BY B. amyloliquefaciens T-5-GFP
To reveal potential trade-offs, the same R. solanacearum colonies
that were used for phage resistance assays were used to determine
the evolution of pathogen defense against antibiotics produced by
ancestral B. amyloliquefaciens T-5-GFP strain. Instead of testing
any specific antibiotic, we tested the inhibitory potential of all
potential exoenzymes produced by the ancestral B. amyloliquefa-
ciens T-5-GFP strain. Briefly, the B. amyloliquefaciens T-5-GFP
was cultured in the liquid nutrient medium for 36 h, after the
bacterial suspension was centrifuged at 10,000 × g for 10 min
and filtered through a 0.22 µm syringe filter to remove bacteria.
Evolved and ancestral R. solanacearum colonies were then grown
at 30°C (200 µl of liquid nutrient medium) in 96-well microplates
in the absence (5 µl of media added) or presence of B. amy-
loliquefaciens T-5-GFP supernatant (5 µl of supernatant added).
Inhibition was measured as the difference of bacterial growth
in the absence (OD600m) and presence (OD600t) of supernatant
as follows: Inhibition effect = (OD600m – OD600t)/OD600m ×
100%.
MEASURING EVOLUTIONARY CHANGES
IN BACTERIAL FITNESS COST (GROWTH
IN THE ABSENCE OF PHAGE AND COMPETITOR)
To test whether bacterial evolution incurred fitness costs, the
growth of evolved bacteria (isolated at 96-h sampling point) was
measured in the absence of phages and B. amyloliquefaciens T-5-
GFP in 96-well microplates (at 30°C in 200 µl of nutrient broth)
as optical density (600 nm at every 4 h for 24 h). These data were
used to count bacterial maximum density (growth at 24-h time
point) and maximum growth rate per hour.
THE EFFECT OF COMPETITORS AND PARASITES
ON BACTERIAL WILT DISEASE DEVELOPMENT,
PATHOGEN DENSITIES, AND PATHOGEN EVOLUTION
IN THE TOMATO RHIZOSPHERE
Tomato seeds (cultivar Hezuo 903) were surface-sterilized by im-
mersing them in 70% alcohol for 1 min. Seeds were then washed
with sterilized water, immersed in household bleach (2% NaClO)
for 5 min, and finally rinsed six times with sterile water. Seeds
were germinated in darkness at 25°C on water-wetted filter paper
in a Petri dish. Germinated seeds were aseptically transferred to
eight-plant seeding tray inserts containing 10 kg of autoclaved soil
(at 121°C for 2 h) collected from Qilin Town, Nanjing (Wei et al.
2011). A total of 48 plants were used for each treatment (12 plants
per replicate, N = 3). The greenhouse experiment included the
same four treatments as described for in vitro tests. Seedlings were
grown in a controlled growth chamber at 28–35°C under a 16-h
light and 8-h dark cycle. At three-leaf stage, a cell suspension
of B. amyloliquefaciens T-5 bacterium was inoculated into the
soil of the seedlings with a final density of approximately 108
cells per gram of dry weight soil. The cell suspension of R.
solanacearum strain QL-Rs1115 (106 cells per gram dry weight
soil) was inoculated 2 days later. Five days after the inoculation of
R. solanacearum, the suspensions of phage particles were added
with a final density of approximately 107 phage particles per gram
of dry weight soil. Plants were then grown in greenhouse condi-
tions for 70 days with natural temperature and light variation
and watered regularly with sterilized water. Bacterial wilt disease
progression was determined at the end of the experiment 40 days
after pathogen inoculation. Disease index was recorded based on
a scale ranging from 0 to 4 (Tans-Kersten et al. 2004), where 0 de-
notes zero disease incidence, 1 denotes 1–25% disease incidence,
2 denotes 26–50% disease incidence, 3 denotes 51–75% disease
incidence, and 4 denotes 76–100% disease incidence.
At the end of the experiment, we randomly chose three
healthy plants and measured R. solanacearum population den-
sities in the rhizosphere soil. To this end, whole plants were
removed, excess soil removed gently by shaking and remain-
ing rhizosphere soil mixed with sterile water and serially diluted
and plated on M-SMSA selective medium. After incubation for
2 days at 30°C, R. solanacearum colonies were counted per gram
dry weight of soil and 24 colonies per replicate plant in each
treatment were isolated to determine R. solanacearum resistance
evolution to ancestral B. amyloliquefaciens T-5 competitor as
described above. Phage resistance to ancestral phage was mea-
sured as the R. solanacearum density reduction in liquid nutrient
broth media. Briefly, R. solanacearum colonies were grown in the
presence (5 µl of media containing 108 phage particles) and the
absence (5 µl of media) of ancestral phage at 30°C in 200 µl of
nutrient broth media for 24 h. Resistance to phage was measured
as the difference of bacterial growth in the absence (OD600a) and
presence (OD600p) of phage as follows: Inhibition by the phage=
(OD600a – OD600p)/OD600a × 100%.
STATISTICAL ANALYSIS
All time-dependent data wer analyzed with repeated-measures
ANOVA by using time and factors as explanatory variables.
Factorial two-way ANOVA was used for all other analyses.
When needed, data were square-root or log10-transformed be-
fore the analyses in order to meet the parametric model assump-
tions (normality and homogeneity of variance). The rate of R.
solanacearum inhibition was calculated as the difference in R.
solanacearum growth alone versus in the presence of phage or
B. amyloliquefaciens. Bacterial resistance to phages was deter-
mined as the proportion of resistant colonies per treatment repli-
cate, and phage infectivity as the proportion of susceptible, R.
solanacearum colonies per treatment replicate. All proportional
data were arcsine-transformed before the analyses to meet the
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Figure 1. The microbial population dynamics during the short-term laboratory experiment. The population densities of Ralstonia
solanacearum pathogen QL-RFP (A), B. amyloliquefaciens T-5-GFP competitor (B), phage (plaque forming units, i.e. PFU) (C) and the
pathogen inhibition rates in different treatments (D). All bars show ± 1 SE.
parametric model assumptions. Disease index was calculated as
described by: Disease index= [ (The number of diseased plants
in the disease index category × disease index category)/ (Total
number of plants used in the experiment × highest disease index
category)] × 100%. All analyses were conducted with R (R Core
Team 2014).
Results
PHAGE- and B. amyloliquefaciens-MEDIATED
CONTROL OF PATHOGEN POPULATION DENSITIES
IN THE LABORATORY EXPERIMENT
Phage negatively affected on the pathogen density at the begin-
ning of the experiment, but this effect vanished through time
(Fig. 1A, D; Table 1a, d). Bacillus amyloliquefaciens had an even
stronger suppressive effect (Fig. 1A, D; Table 1a, d), and even
though some changes in time were observed, the reduction was
more consistent compared to the effect of the phage (Fig. 1A,
D; Table 1a, d). Interestingly, phage and B. amyloliquefaciens
decreased pathogen densities most efficiently in combination in-
dicative of a synergistic effect (Fig. 1A, D; Table 1a, d). One
explanation for this could be that both phages and B. amyloliq-
uefaciens had higher population densities when cultured together
leading to more efficient pathogen density reduction. However,
no difference was found between B. amyloliquefaciens densities
in single versus combinatory treatments (Fig. 1B, Table 1b), and
similarly, B. amyloliquefaciens had only a very small negative
effect on the phage densities (Fig. 1C, Table 1c). These results
suggest that phage and B. amyloliquefaciens showed additive syn-
ergistic effects at reducing pathogen densities.
BACTERIA–PHAGE COEVOLUTION DURING
THE LABORATORY EXPERIMENT
Phage selection led to evolution of high levels of phage resistance
both in the absence and presence of B. amyloliquefaciens, while no
increase in resistance was observed when pathogen had evolved
alone or in the competition treatment (Fig. 2A, Table 1e). The
sampling time point (after 48 or 96 h of selection) did not affect
the level of phage resistance to ancestral phage (Fig. 2A, Table 1e).
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Table 1. Statistical analyses.
Source of variation df
sum of squares
within groups
mean square
within groups F P
(a) The Ralstonia solanacearum pathogen population densities (laboratory experiment)
Error: factor(id)
Phage 1 33.66 33.66 5235 <2 × 10–16∗∗∗
T5 1 42.58 42.58 6621 <2 × 10–16∗∗∗
Phage × T5 1 6.73 6.73 1047 <2 × 10–16∗∗∗
Residuals 20 0.13 0.01
Total 23 83.1 82.98
Error: Within
Time 3 17.359 5.786 1057.37 <2 × 10–16∗∗∗
Phage × Time 3 8.691 2.897 529.38 <2 × 10–16∗∗∗
T5 × Time 3 5.664 1.888 345.02 <2 × 10–16∗∗∗
Phage × T5 × Time 3 0.418 0.139 25.48 9.37 × 10–16∗∗∗
Residuals 60 0.328 0.005
Total 72 32.46 10.715
(b) The B. amyloliquefaciens T-5 competitor population densities (laboratory experiment)
Error: factor(id)
Phage 1 0.02024 0.020238 4.904 0.0512
Residuals 10 0.04127 0.004127
Total 11 0.06151 0.024365
Error: Within
Time 3 0.7632 0.25441 262.11 <2 × 10–16∗∗∗
Phage × Time 3 0.0269 0.00895 9.226 0.000177∗∗∗
Residuals 30 0.0291 0.00097
Total 36 0.8192 0.26433
(c) The phage population densities (laboratory experiment)
Error: factor(id)
T5 1 0.02159 0.02159 8.511 0.0434∗
Residuals 4 0.01015 0.002537
Total 5 0.03174 0.024127
Error: Within
Time 1 0.0274 0.027399 2.464 0.192
T5 × Time 1 0.00524 0.005242 0.471 0.53
Residuals 4 0.04448 0.011119
Total 6 0.07712 0.04376
(d) The pathogen inhibition rates by B. amyloliquefaciens T-5 competitor in different treatments (laboratory experiment)
Error: factor(id)
Phage 1 0.0113 0.0113 8.288 0.0115∗
T5 1 1.2083 1.2083 889.867 9.04 × 10–15∗∗∗
Residuals 15 0.0204 0.0014
Total 17 1.24 1.221
Error: Within
Time 3 0.313 0.1043 129.3 <2 × 10–16∗∗∗
Phage × Time 3 1.0699 0.3566 441.9 <2 × 10–16∗∗∗
T5 × Time 3 0.9298 0.3099 384.1 <2 × 10–16∗∗∗
Residuals 45 0.0363 0.0008
Total 54 2.349 0.7716
(e) The evolution of pathogen resistance to ancestral phage (laboratory experiment)
Error: factor(id)
Phage 1 8.435 8.435 191.7 7.16 × 10–16∗∗∗
T5 1 0.044 0.044 1.01 0.344
Phage × T5 1 0.031 0.031 0.71 0.424
Residuals 8 0.352 0.044
Total 11 8.862 8.554
(Continued)
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Table 1. Continued.
Source of variation df
sum of squares
within groups
mean square
within groups F P
(e) The evolution of pathogen resistance to ancestral phage (laboratory experiment)
Error: Within
Time 1 0.02193 0.021934 2.399 0.16
Phage × Time 1 0.00638 0.00638 0.698 0.4276
T5 × Time 1 0.02147 0.02147 2.348 0.1639
Phage × T5 × Time 1 0.03263 0.03263 3.57 0.0955
Residuals 8 0.07313 0.00914
Total 12 0.15554 0.091554
(f) The evolution of pathogen resistance to contemporary phages (laboratory experiment)
Error: factor(id)
T5 1 0.09891 0.09891 7.412 0.0529
Residuals 4 0.05338 0.01334
Total 5 0.15229 0.11225
Error: Within
Bacterial isolation time point 2 5.535 2.7674 342.3 1.78 × 10–08∗∗∗
T5 × Bacterial isolation time point 2 0.28 0.1399 17.3 0.00124∗∗
Residuals 8 0.065 0.0081
Total 12 5.88 2.9154
(g) The phage infectivity to contemporary pathogen (laboratory experiment)
Error: factor(id)
T5 1 0.0497 0.0497 1.254 0.326
Residuals 4 0.1586 0.03964
Total 5 0.2083 0.08934
Error: Within
Phage isolation time point 2 4.644 2.3221 105.205 1.8 × 10–06∗∗∗
T5 × Phage isolation time point 2 0.035 0.0176 0.797 0.484
Residuals 8 0.177 0.0221
Total 12 4.856 2.3618
(h) The susceptibility of evolved pathogen to antibiotics produced by ancestral T-5 B. amyloliquefaciens competitor
(laboratory experiment)
Error: factor(id)
Phage 1 0.10846 0.10846 107.217 6.54 × 10–06∗∗∗
T5 1 0.01482 0.01482 14.652 0.00503∗∗
Phage × T5 1 0.10846 0.00267 2.635 0.14319
Residuals 8 0.00809 0.00101
Total 11 0.23983 0.12696
Error: Within
Time 1 0.026521 0.026521 18.234 0.00272∗∗
Phage × Time 1 0.011865 0.011865 8.157 0.02128∗
T5 × Time 1 0.005042 0.005042 3.466 0.09966
Phage × T5 × Time 1 0.016804 0.016804 11.553 0.00937∗∗
Residuals 8 0.011636 0.001454
Total 12 0.071868 0.061686
(i) The evolved pathogen maximum density in the absence of phage or competitor (laboratory experiment)
Phage 1 0.163 0.163 24.565 0.001
T5 1 0.252 0.252 38.081 <0.001
Phage × T5 1 0.145 0.145 21.833 0.002
Residual 8 0.053 0.00663
Total 11 0.613 0.0557
(Continued)
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Table 1. Continued.
Source of variation df
sum of squares
within groups
mean square
within groups F P
(j) The evolved pathogen maximum growth rate in the absence of phage or competitor (laboratory experiment)
Phage 1 0.0000553 0.0000553 0.674 0.435
T5 1 0.000108 0.000108 1.321 0.284
Phage × T5 1 0.0000059 0.0000059 0.0719 0.795
Residual 8 0.000656 0.0000821
Total 11 0.000826 0.0000751
(k) The tomato wilt disease incidence (greenhouse experiment)
Phage 1 102.083 102.083 10.419 0.012
T5 1 198.047 198.047 20.213 0.002
Phage × T5 1 0 0 0 1
Residual 8 78.385 9.798
Total 11 378.516 34.411
(l) The pathogen density in the rhizosphere soil (greenhouse experiment)
Phage 1 0.322 0.322 22.706 <0.001
T5 1 5.798 5.798 409.467 <0.001
Phage × T5 1 0.32 0.32 22.586 <0.001
Residual 12 0.17 0.0142
Total 15 6.609 0.441
(m) The evolution of pathogen resistance to ancestral phage (greenhouse experiment)
Phage 1 6.29 × 10–07 6.29 × 10–07 0.327 0.583
T5 1 0.0000162 0.0000162 8.425 0.02
Phage × T5 1 2.32 × 10–06 2.32 × 10–06 1.201 0.305
Residual 8 0.0000154 1.93 × 10–06
Total 11 0.0000346 3.15 × 10–06
(n) The evolution of pathogen resistance to antibiotics produced by ancestral T-5 B. amyloliquefaciens competitor
(greenhouse experiment)
Phage 1 0.0234 0.0234 138.235 <0.001
T5 1 0.00629 0.00629 37.235 <0.001
Phage × T5 1 0.00216 0.00216 12.807 0.007
Residual 8 0.00135 0.000169
Total 11 0.0332 0.00302
To explore changes in bacteria–phage coevolution, we mea-
sured the resistance of pathogen isolated from the past (0 h),
contemporary (48 h), and future (96 h) time points to phages iso-
lated at the contemporary time point (48 h, Fig. 2B). Similarly,
we measured the contemporary phages’ (48 h) ability to infect
pathogen isolated from the past (0 h), contemporary (48 h), and
future time points (96 h, Fig. 2C). We found that pathogen and
phage underwent short-term arms race coevolutionary dynamics
in both the absence and presence of competitor: both the bacterial
resistance and phage infectivity increased in time (Fig. 2B, C;
Table 1f–g). In other words, pathogens from the future were more
resistant to the contemporary phages compared to the pathogens
from the past, while phages from the future were more infective to
the contemporary pathogen compared to the phages from the past.
Bacteria–phage coevolution was not affected by the presence of
B. amyloliquefaciens competitor (Fig. 2B, C; Table 1f–g). These
results suggest that R. solanacearum pathogen and the phage co-
evolved rapidly in the laboratory experiment leading to increase
in bacterial resistance and phage infectivity.
EVOLUTION OF BACTERIAL RESISTANCE TO
B. amyloliquefaciens T-5-GFP COMPETITOR
We found that exposing pathogen to phage affected its ability
to resist antibiotics produced by B. amyloliquefaciens (Fig. 3,
Table 1h). While the ancestral and evolved pathogens from the
control and competitor treatments showed very low and simi-
lar susceptibilities to B. amyloliquefaciens antibiotics, evolved
pathogens isolated from the phage-only and the phage–competitor
treatments showed increased susceptibility to B. amyloliquefa-
ciens antibiotics compared to control treatments (Fig. 3, Table
1h). Crucially, the pathogen susceptibility to B. amyloliquefa-
ciens antibiotics increased significantly the longer the bacteria
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Figure 3. The evolved pathogen susceptibility to antibiotics pro-
duced by ancestral B. amyloliquefaciens T-5 strain during the
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ity of R. solanacearum pathogen to the antibiotics produced by
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had been coevolving with the phage and became greatest in the
combinatory treatment (Fig. 3, Table 1h). These results suggest
that evolving resistance to phage leads to increased susceptibility
to antibiotics produced by B. amyloliquefaciens T-5 strain.
FITNESS COST OF BACTERIAL ADAPTATION DURING
THE LABORATORY EXPERIMENT
To determine the costs associated with evolving with phages and
competitors, we measured both the maximum densities and max-
imum growth rates of evolved pathogen populations in the ab-
sence of phage and competitor. While phage and T-5 selection
alone led to reduced pathogen maximum densities, this was driven
by synergistic interaction and clear reduction in pathogen maxi-
mum densities was observed only in the combinatory treatment
(Fig. 4A, Table 1i). Phage and B. amyloliquefaciens T-5 selection
had no effect on the pathogen growth rate (Fig. 4B, Table 1j).
These results suggest that R. solanacearum pathogen suffered a
relatively higher cost of adaptation in the combinatory treatment.
THE EFFECT OF COMPETITORS AND PARASITES
ON PATHOGEN DENSITIES, RESISTANCE EVOLUTION,
AND BACTERIAL WILT DISEASE DEVELOPMENT
IN THE TOMATO RHIZOSPHERE
Phage and competitor reduced disease incidence (the proportion
of wilted plants showing disease symptoms) when applied alone
(Fig. 5A, Table 1k). However, the effect of competitor was
relatively stronger showing similar synergy with the phage as
observed in the laboratory experiment (Fig. 5A, Table 1k; despite
the nonsignificant interactions significant contrasts found with
one-way ANOVA). Pathogen densities generally increased from
the initial inoculation of 106 CFU/g soil reaching levels com-
parable to field conditions (Wei et al. 2011, 2015b). Crucially,
the pathogen densities correlated well with the level of disease
incidence: even though phage and competitor reduced pathogen
densities alone, they had the strongest effect when applied
together (Fig. 5B, Table 1l). To examine evolutionary changes in
the rhizosphere, we compared the resistance of evolved pathogens
in the end of the greenhouse experiment. Only low levels of
resistance were observed in general and pathogens showed
clearly reduced growth in the presence of the ancestral phage
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regardless of their evolutionary history (Fig. 5C). Interestingly,
pathogens that had evolved in the presence of competitor showed
slightly higher susceptibility to the ancestral phage compared to
other treatments (Fig. 5C, Table 1m). Despite the low levels of
resistance, pathogens isolated from the phage treatments showed
increased susceptibility to the antibiotics produced by ancestral
B. amyloliquefaciens T-5 strain (Fig. 5D, Table 1n). Together,
these results demonstrate that phages and competitors can
suppress bacterial pathogen synergistically due to evolutionary
trade-off and that in vitro experiments can qualitatively predict
microbial interactions in the rhizosphere in vivo.
Discussion
Here, we studied how B. amyloliquefaciens bacterial competi-
tor and parasitic phage affected the population densities and re-
sistance evolution of a R. solanacearum pathogen alone and in
combination in the laboratory and plant rhizosphere. We found
that B. amyloliquefaciens exerted stronger antagonism toward the
pathogen compared to the phage. In addition, the combination
of phage and B. amyloliquefaciens showed additive synergistic
effects and reduced pathogen densities and bacterial wilt dis-
ease incidence most effectively. Rather than density effects, this
synergy could be explained with phage-driven increase in phage
resistance, which made pathogens more susceptible to antibiotics
produced by B. amyloliquefaciens. Such evolutionary trade-offs
could offer novel ways to control bacterial infections both in med-
ical and agricultural settings.
We found that pathogen was able to evolve resistance to
phage very rapidly under laboratory conditions, which also likely
explains the loss of phage-mediated pathogen control. However,
the phages were also able to coevolve and become more infec-
tive, which raises a question: why was the phage unable to evolve
to control pathogen population densities? One explanation for
this is that our sampling regime was not frequent enough to cap-
ture phage-mediated reduction in pathogen densities (Friman and
Buckling 2013, 2014). Moreover, evolving resistance to a phage
incurred only a weak cost (slightly reduced growth rate), which
likely weakened the phage-mediated density regulation allowing
rapid fixation of new resistance mutations in the pathogen pop-
ulations. It is also possible that evolving a higher infectivity was
costly for the phage leading to less effective reproduction. Even
though more detailed studies are needed to uncover the exact
mechanism, our results are in line with previous studies reporting
continuous phage–bacteria coevolutionary arms race even in the
absence of bacterial population density regulation by the phage
(Hall et al. 2011). In contrast, we found that B. amyloliquefaciens
reduced pathogen densities effectively and consistently in the lab-
oratory conditions, which is in line with previous findings (Tan
et al. 2013). No evidence for pathogen resistance evolution to B.
amyloliquefaciens was found. One potential explanation is that
the timescale of the laboratory experiment was not long enough
for the emergence of resistance mutations. Moreover, B. amy-
loliquefaciens is known to simultaneously produce many different
lipopeptide antibiotics (Ongena and Jacques 2008). Even though
we did not characterize the antibiotic composition in more detail,
it has been shown that concurrent selection by multiple clinical
antibiotics is less likely to select for increased resistance (Davies
and Davies 2010), which could have also explained the lack of
resistance evolution in our experiment.
Interestingly, phage and B. amyloliquefaciens had addi-
tive synergistic effects leading to highest reduction in pathogen
densities. This result could be explained by ecological and/or
evolutionary dynamics. First, it is possible that phage and B.
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amyloliquefaciens had higher densities when cultured together,
which could have led to more efficient pathogen density reduc-
tion. In contrast, we found that phage and B. amyloliquefaciens
had equally high, or even slightly lower, densities when cul-
tured together versus alone. This suggests that the synergistic
antagonism was less likely to be explained by population den-
sity effects. We next looked if phage–B. amyloliquefaciens syn-
ergy could be explained by evolutionary constraints. In support
for this, we found that phage selection increased pathogen sus-
ceptibility to the antibiotics produced by B. amyloliquefaciens
T-5-GFP ancestral bacteria. Phages often target the receptors in
LPS (lipopolysaccharides) (Tamaki et al. 1971; da Costa et al.
2014), which is also the target of B. amyloliquefaciens produced
lipopeptides (Sequeira and Graham 1977). Therefore, it is pos-
sible that phage-mediated changes in R. solanacearum LPS also
affected its susceptibility to B. amyloliquefaciens antibiotics. This
result is line with a recent finding where phage selection was
shown to impair the outer membrane porin M (OprM) of the
multidrug efflux systems MexAB and MexXY of human oppor-
tunistic pathogen Pseudomonas aeruginosa (Chan et al. 2016).
Together, these results suggest that PAS could efficiently con-
trol bacterial infections in both agricultural and clinical contexts.
We also found that evolving in the presence of both phage and
B. amyloliquefaciens incurred a relatively higher fitness cost in
terms of reduced pathogen growth in the absence of phage or com-
petitor (maximum density). This growth cost could also have re-
sulted from defective LPS and could have made the pathogen less
infective.
The population and evolutionary dynamics showed qual-
itatively similar patterns between laboratory and greenhouse
experiments. First, the pathogen density dynamics correlated
well with bacterial wilt disease dynamics in the rhizosphere
and even though phage alone had no clear effect on disease
incidence or pathogen densities, B. amyloliquefaciens reduced
pathogen densities both in the absence and presence of phages.
Bacillus amyloliquefaciens-mediated pathogen density reduction
was clearest in the combinatory treatment. This suggests that
simple laboratory experiments can qualitatively predict microbial
interactions in much more complex rhizosphere. One crucial dif-
ference between these study systems was that the level of phage
resistance evolved considerably lower in the rhizosphere. This
could have been due to spatial heterogeneity of the soil, which
could have lowered bacteria–phage encounter rates and strength
of selection, or alternatively, due to the presence of natural
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microbial competitors that could have constrained pathogen and
phage population densities (Gomez and Buckling 2011; Gomez
et al. 2015). Despite the difference in the level of resistance, phage
selection still increased the pathogen susceptibility to ancestral
B. amyloliquefaciens antibiotics. This result is in line with recent
study showing clear PAS without clear changes in pathogen phage
resistance evolution (Torres-Barcelo et al. 2016). Alternatively, it
is possible that pathogen and phage showed fluctuating coevolu-
tionary dynamics in the soil and potentially lost their resistance
to ancestral phage (Gomez and Buckling 2011). Pathogen could
have thus evolved different levels of resistance to their contempo-
rary phages in different treatments but we missed this because the
resistance of evolved pathogens was measured only against the
ancestral phage. More work is thus needed to better understand
how phage selection affects the susceptibility to B. amyloliq-
uefaciens antibiotics. Despite the lack of exact mechanism, our
results suggest that even low levels of phage resistance can
impose strong evolutionary trade-offs for pathogen survival in the
rhizosphere.
The combinatory treatment led to around 40% reduction in
bacterial wilt disease incidence during the greenhouse experiment.
It has been found previously that B. amyloliquefaciens T-5 alone
can confer up to 65% disease control efficiency depending on the
crop season and the environmental temperature (Wei et al. 2015a).
In our experiment, the B. amyloliquefaciens-mediated biocontrol
had a relatively smaller effect on its own. One reason for this dif-
ference could be that in contrast to previous studies we did not use
organic fertilizer as a carrier for the B. amyloliquefaciens, but in-
stead, inoculated the biocontrol agents directly to the rhizosphere
soil. This suggests that B. amyloliquefaciens biocontrol efficiency
could be also shaped by organic nutrients provided by organic fer-
tilizers (Wei et al. 2011). The lack of phage effect could have been
due to low phage survival in the rhizosphere (Gomez et al. 2015).
Determining, and potentially improving, the phage survival in the
rhizosphere will be studied in the future experiments.
In conclusion, here we show that evolutionary dynamics are
important for regulating pathogen densities and subsequent dis-
ease dynamics in the plant microbiome: while selection by a phage
led to rapid increase in phage resistance, this made the resistant
pathogen genotypes more susceptible to the antibiotics produced
by B. amyloliquefaciens T-5, and lowered pathogen competitive
ability in terms of reduced growth. Together these results suggest
that evolution of species interactions depends on the community
context and that pathogen biocontrol could be potentially im-
proved by using multiple biocontrol agents that show synergistic
effects at ecological or evolutionary level. In more general per-
spective, our results suggest that host–parasite interactions are
sensitive to competitive interactions, and that rapid evolutionary
dynamics are likely to be important for shaping disease dynamics
in natural environments.
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Figure S1. (A) The phage plaque morphology on bacterial overlay plates after 24 h of incubation at 30°C.
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